fda tirzepatide weight loss is FDA-approved for management, with clinical trials showing average weight of 15–22.5% over 72 weeks. It's a prescription-only therapy, meaning it's not for everyone, and it works by acting GLP-1 Medications for Weight Loss:

Consuming 150g of protein daily combined with resistance training 3x weekly prevents 85% of muscle loss-related fatigue

They received once-weekly subcutaneous injections of either 5 mg, 10 mg, or 15 mg of tirzepatide or a placebo over a period of 40 weeks

If theres another option in the arsenal of weight loss drugs, thats greatbut a full-on comparison to tirzepatide will need to be determined

While gastrointestinal effects like nausea and diarrhea are well-documented, nightmares are not listed among recognized adverse reactions in FDA prescribing information or clinical trial data

Their headquarters sit at 6586 West Atlantic Avenue in Delray Beach, Florida